Production of proinflammatory cytokines in the human THP-1 monocyte cell line following induction by Tp0751, a recombinant protein of Treponema pallidum.
The tissue destruction characteristic of syphilis infection may be caused by inflammation due to Treponema pallidum and the ensuing immune responses to the pathogen. T. pallidum membrane proteins are thought to be potent inducers of inflammation during the early stages of infection. However, the actual membrane proteins that induce inflammatory cytokine production are not known, nor are the molecular mechanisms responsible for triggering and sustaining the inflammatory cascades. In the present study, Tp0751 recombinant protein from T. pallidum was found to induce the production of proinflammatory cytokines, including TNF-alpha, IL-1beta and IL-6, in a THP-1 human monocyte cell line. The signal transduction pathways involved in the production of these cytokines were then further investigated. No inhibition of TNF-a, IL-1beta, or IL-6 production was observed following treatment with the SAPK/JNK specific inhibitor SP600125 or with an ERK inhibitor PD98059. By contrast, anti-TLR2 mAb, anti-CD14 mAb, and the p38 inhibitor SB203580 significantly inhibited the production of all three cytokines. In addition, pyrrolidine dithiocarbamate (PDTC), a specific inhibitor of NF-kappaB, profoundly inhibited the production of these cytokines. Tp0751 treatment strongly activated NF-kappaB, as revealed by Western blotting. However, NF-kappaB translocation was significantly inhibited by treatment with PDTC. These results indicated that TLR2, CD14, MAPKs/p38, and NF-kappaB might be implicated in the inflammatory reaction caused by T. pallidum infection.
Liu
ShuangQuan
S
Department of Parasitology, Xiangya School of Medicine, Central South University, Changsha, 410078, China.
Wang
ShiPing
S
Wu
YiMou
Y
Zhao
FeiJun
F
Zeng
TieBing
T
Zhang
YueJun
Y
Zhang
QiuGui
Q
Gao
DongMei
D
D001426:Bacterial Proteins / Q000494:pharmacology*; D002460:Cell Line; D016207:Cytokines / Q000096:biosynthesis* / Q000378:metabolism* / Q000494:pharmacology; D004789:Enzyme Activation; D006801:Humans; D053583:Interleukin-1beta; D015850:Interleukin-6 / Q000378:metabolism; D009000:Monocytes / Q000378:metabolism*; D016328:NF-kappa B / Q000378:metabolism / Q000502:physiology; D011759:Pyrrolidines; D011994:Recombinant Proteins / Q000494:pharmacology; D015398:Signal Transduction / Q000187:drug effects; D013859:Thiocarbamates; D014210:Treponema pallidum / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis / Q000378:metabolism / Q000494:pharmacology
D001426:Bacterial Proteins; D016207:Cytokines; D053583:Interleukin-1beta; D015850:Interleukin-6; D016328:NF-kappa B; D011759:Pyrrolidines; D011994:Recombinant Proteins; D013859:Thiocarbamates; D014409:Tumor Necrosis Factor-alpha; C020972:pyrrolidine dithiocarbamic acid